Novel biomaterials for ocular drug delivery and a method for making and using same

Details for Australian Patent Application No. 2008211083 (hide)

Owner Allergan, Inc.

Inventors Chang, James N.; Youso, Patrick D.; Utecht, Ronald E.; Kloster, Kaia L.; Haberer, Barbara R.; Downey, Therese M.

Agent Davies Collison Cave

Pub. Number AU-A-2008211083

PCT Pub. Number WO2008/094659

Priority 60/887,559 31.01.07 US

Filing date 31 January 2008

Wipo publication date 7 August 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/094659 Priority application(s): WO2008/094659

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008211097-Use of abscisic acid to alter sensory characteristics of red grapes and wine

2008211082-Highly porous self-cohered fibrous tissue engineering scaffold